Background and Objectives: Microsatellite instability (MSI) in gastric cancer (GC) is associated with older age. We present the clinicopathological results of younger and older patients with MSI GC. Methods: We analyzed 472 patients with GC. MSI analysis was done on fresh frozen tissue using five quasimonomorphic mononucleotide repeats: NR-21, NR-24, NR-27, BAT-25, and BAR-26. Clinical and pathological analysis was performed for different age groups. Results: We observed better survival in elderly MSI GC patients compared to younger patients. The percentage of MSI GC increases gradually with increasing age, accounting for 48% of patients over the age of 85 years. A difference in survival was seen between MSI and MSS groups of patients older than 65 years, while no statistical difference was seen for younger groups. Multivariate analysis revealed that MSI status has a significant prognostic factor in patients aged over 70 years (MSS vs. MSI; HR 1.82, P = 0.013). Conclusion: MSI is an important prognostic factor above all in elderly GC patients. It is associated with favorable prognosis and may help in planning different approaches to treatment in this subgroup. J. Surg. Oncol. 2017;115:344–350. © 2016 Wiley Periodicals, Inc.

Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability / POLOM, KAROL ROMAN; MARRELLI, DANIELE; ROVIELLO, GIANDOMENICO; PASCALE, VALERIA; VOGLINO, COSTANTINO; Rho, Henry; MARINI, MARIO; MACCHIARELLI, RAFFAELE; ROVIELLO, FRANCO. - In: JOURNAL OF SURGICAL ONCOLOGY. - ISSN 0022-4790. - STAMPA. - 115:(2017), pp. 344-350. [10.1002/jso.24513]

Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability

ROVIELLO, GIANDOMENICO;
2017

Abstract

Background and Objectives: Microsatellite instability (MSI) in gastric cancer (GC) is associated with older age. We present the clinicopathological results of younger and older patients with MSI GC. Methods: We analyzed 472 patients with GC. MSI analysis was done on fresh frozen tissue using five quasimonomorphic mononucleotide repeats: NR-21, NR-24, NR-27, BAT-25, and BAR-26. Clinical and pathological analysis was performed for different age groups. Results: We observed better survival in elderly MSI GC patients compared to younger patients. The percentage of MSI GC increases gradually with increasing age, accounting for 48% of patients over the age of 85 years. A difference in survival was seen between MSI and MSS groups of patients older than 65 years, while no statistical difference was seen for younger groups. Multivariate analysis revealed that MSI status has a significant prognostic factor in patients aged over 70 years (MSS vs. MSI; HR 1.82, P = 0.013). Conclusion: MSI is an important prognostic factor above all in elderly GC patients. It is associated with favorable prognosis and may help in planning different approaches to treatment in this subgroup. J. Surg. Oncol. 2017;115:344–350. © 2016 Wiley Periodicals, Inc.
2017
115
344
350
POLOM, KAROL ROMAN; MARRELLI, DANIELE; ROVIELLO, GIANDOMENICO; PASCALE, VALERIA; VOGLINO, COSTANTINO; Rho, Henry; MARINI, MARIO; MACCHIARELLI, RAFFAELE; ROVIELLO, FRANCO
File in questo prodotto:
File Dimensione Formato  
J SURG ONCOL 2017 MOLECULAR KEY.pdf

Accesso chiuso

Dimensione 666.93 kB
Formato Adobe PDF
666.93 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1156814
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 22
social impact